PO-0686: Larger tumor bed delineation volumes in irradiated breast cancer patients after oncoplastic surgery  by Maduro, J.H. et al.
3rd ESTRO Forum 2015                                                                                                                                         S335 
 
 
Conclusions: At the moment the Partial Breast Irradiation is 
a procedure still under investigation as it is encumbered by 
high risk of local relapse as compared with external beam (OS 
is similar), as confirmed also by our study. Nevertheless it 
gained a great appeal among women and the IORT can be 
offered to accurately selected pts.  
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Purpose/Objective: Axillary lymph node dissection (ALND) 
and adjuvant radiotherapy (RT) in breast cancer is associated 
with a risk of severe morbidity including lymphoedema, 
impaired function of the arm and chronic pain/sensory 
disability. The aim of this study was to evaluate the 
morbidity in two groups of heavily treated adjuvant breast 
cancer patients, differing only regarding inclusion or not of 
regional nodes in the RT volume.  
Materials and Methods: 347 patients consecutively operated 
from 2007-2012 with breast conservative surgery (BCS) and 
ALND (>= 3 micro- or macrometastases in sentinel node (SN) 
or SN not identified). All patients received adjuvant taxane 
based chemotherapy and if indicated, trastuzumab and 
endocrine treatment. The RT consisted of whole breast 
irradiation (WBI) to patients with pN0 and pN1mi disease and 
loco-regional RT in case of >= pN1 disease. The dose was in 
all patients 50 Gy in 25 fx. Only patients without recurrence 
were eligible for the study. They were invited to participate 
in a cross-sectional study regarding evaluation of objective 
physical impairments, and filling out a questionnaire 
regarding morbidity.  
Results: 277 patients participated. Of these, 185 patients 
(>=pN1), median 15 removed axillary nodes, received loco-
regional RT, median follow up 3.3 years, while 92 patients 
(pN0, pN1mi), median 16 removed axillary nodes, received 
WBI, median follow up 4.3 years. 
Circumferential ipsilateral arm difference of >= 2 cm of 
upper and/or lower arm was seen in 18% after loco-regional 
RT and in 16% after WBI (p=0.67). An increase of >= 10 % in 
ipsilateral upper and/or lower arm circumference was seen in 
8% (loco-regional RT) vs 3% (WBI) (p=0.12) and if this was 
combined with weekly use of an arm sleeve these numbers 
were 19% (loco-regional RT) versus 15% (WBI) (p=0.39). Self 
reported lymphoedema of ipsilateral upper/lower arm was 
found in 44%/33% (loco-regional RT) and in 40%/29% after WBI 
(p=NS).  
Severe impairments of shoulder function with abduction to 
120° or less was 3% after both loco-regional RT and WBI and 
severe impairments of shoulder flexion to 120° or less were 
1% and 2%, respectively. In the contralateral arm severe 
reduction of abduction/flexion was seen in 0.7%. No 
differences in self reported physical impairment, pain or 
sensory disturbances were seen between the two groups. 
Conclusions: Clinical lymphoedema is seen in about 15-20% 
of patients after ALND and is not dependent on the type of 
RT (WBI or loco-regional RT). Severe impairment of shoulder 
function is rare and not influenced by including regional 
nodes in the RT volume. Awareness of morbidity is important 
to improve future treatment strategies in heavily treated 
breast cancer patients.  
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Purpose/Objective: To investigate the impact in locoregional 
recurrence (LRR) of omission of axillary irradiation (axillary 
level I-II) in patients with ≥7 pathological positive axillary 
lymph nodes (>7pN+) and to identify prognosis factors 
associated in breast cancer patients. 
Materials and Methods: A retrospective database was used to 
identify patients undergoing BCT (breast conserving 
treatment), adjuvant CT (chemotherapy) and radiation 
therapy (RT) from 2000 to 2011. Patients treated with neo-
adjuvant chemotherapy (NCT) were excluded. This study 
analysed 100 patients (34 pN2 and 66 pN3). RT was delivered 
to the chest wall or wall breast and internal lymph nodes 
[internal mammary chain (IMC), supraclavicular, 
infraclavicular and axillary level III]. Disease free survival 
(DFS), metastasis free survival 5(MFS) and overall survival 
were analysed using the Kaplan-Meier method and compared 
using the log-rank test. Cox's proportional hazards regression 
models.  
Results: With a median follow-up time of 63.2 months, 3 
patients relapsed in not irradiated axillary region (1 isolated 
and 2 concomitant with distant metastasis). The median 
removed lymph nodes were 16 and the median lymph node 
ratio (LNR) was 0.8. The five years DFS, MFS and OS was 50%, 
58% and 69.9% respectively. Univariate and multivariate 
analysis showed that triple-negative histologic subtype was 
associated with DFS (HR 3.34 [1.59 ; 7.05] ;p=0.02), MFS (HR 
3.85 [1.59 ;9.29]; p=0.003) and OS (HR 5.77 [2.41 ;13.80]; 
p<0.001). 
Conclusions: The omission of axillary irradiation (level I-II) in 
patient underwent to BCT with an appropriate axillary lymph 
node dissection showed a low rate of regional relapse. Triple-
negative histological subtype in the most important prognosis 
factor in this population. Further prospective studies are 
necessary to assess the clinical impact of the omission of 
axillary irradiation.  
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Purpose/Objective: To investigate the impact of surgery, 
oncoplastic surgery versus lumpectomy, on the volume of 
tumor bed delineation in irradiated breast cancer (BC) 
patients. 
Materials and Methods: A consecutive series of 293 BC 
patients were treated with breast conserving surgery 
followed by radiotherapy. Of this series, 44 patients 
underwent an oncoplastic procedure and were included in 
this study. The control group consisted of 67 patients who 
underwent a lumpectomy. The controls were matched for 
location (lateral upper quadrant versus other) and tumor to 
breast ratio (small versus large). For the small tumor to 
breast ratio group we included 2 controls for each 
oncoplastic patient. For the group with large tumor to breast 
ratios we included all available patients (1 to 1). The tumor 
bed was delineated based on the presence of the surgical 
clips, hematoma, seroma and/or other surgery-induced 
changes and interpretation of radiology, pathology and 
surgical reports. The association between surgery 
(oncoplastic surgery versus lumpectomy) and delineated 
tumor bed volumes in cm3 was assessed with linear regression 
analyses. Here we present the crude association (using 
univariable analysis) and the association corrected for 
confounding factors (using multivariable analysis). Only 
confounders that changed the association more than 10% 
were included. In these analyses the outcome delineated 
tumor bed volume was log-transformed, the estimated beta’s 
represent the change in log tumor bed volume.  
Results: The oncoplastic operated patients had a radiological 
larger median tumor diameter (21 mm versus 14 mm) than 
the lumpectomy patients. The volume of the pathological 
specimen was not significantly different between the two 
groups: 148.8 cm3 in the oncoplastic group and 135.0 cm3 in 
the lumpectomy group. The median delineated tumor bed 
volume was significantly larger after oncoplastic surgery 
compared to lumpectomy alone (26.3 cm3 vs. 16.4 cm3, 
p<0.001). In the univariable analysis the delineated tumor 
bed volume was 1.7 (β = 0.547, 95% CI 0.297-0.797) times 
larger in patients with an oncoplastic procedure than in the 
patients who underwent a lumpectomy only. After correcting 
for confounders (presence of postoperative seroma and 
radiological tumor diameter (mm)) the delineated tumor bed 
volume after the oncoplastic procedure was 1.9 (β = 0.616, 
95% CI 0.353-0.879) times larger than after a lumpectomy 
only. 
Conclusions: Oncoplastic surgery in breast conserving 
treatment for breast cancer results in larger tumor bed 
volumes for radiotherapy. 
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Purpose/Objective: Neoadjuvant radiochemotherapy (NRT-
CHX) is an innovative technique for the treatment of patients 
with locally advanced non inflammatory breast cancer 
(LABC). The aim of this study was to analyze the long term 
cosmetic outcome in breast conserving and mastectomy 
patients after NRT-CHX. 
Materials and Methods: In a time period from 1991 to 1998 a 
total of 315 LABC patients (cT1-cT4/cN0-N1) were treated 
with NRT-CHX. 160 patients received breast conserving 
surgery (BCS) and 154 patients mastectomy. One patient had 
no surgery. Preoperative radiotherapy (RT) consisted of 
external beam radiation therapy (EBRT) of 50 Gy (5 × 2 
Gy/week) to the breast and the supra-/infraclavicular lymph 
nodes (n=255) combined with a consecutive electron boost in 
214 cases or - a 10-Gy interstitial boost with (192)Ir 
afterloading before EBRT in n=101 cases. Chemotherapy with 
CMF and AC/EC was administered prior to RT in 192 patients, 
and Mitoxantrone concomitantly in n=113 patients; 10 
patients received no chemotherapy. The cosmetic outcome 
was assessed by patient questionnaire in 2013. A panel with 5 
independent investigators evaluated the cosmetic outcome in 
4 grades (excellent, good, moderate and bad). The breast 
retraction assessment (BRA) was quantified by van Limbergen 
Score. Quality-of-life was measured by EORTC QLQ-C30 and 
BR23 and late radiation side effects by LENT/SOMA scale. 
Results: In 64 patients after breast conserving surgery and 43 
patients after mastectomy a long term follow up of the 
cosmetic outcome was possible. Most patients rated their 
overall cosmetics as 'excellent' or 'good' (94% in the breast 
conserving group and 55.8% of the mastectomy group). The 
results for the mastectomy group is in detail: excellent: 
27.91%, good: 27.91%, moderate: 39.53% and bad 4.65%. 
After a follow up of 16-22 years we did not detect any grade 
III or IV late side effects in both groups. The median BRA 
score after breast conserving surgery was 2.9 and the over-all 
quality of life (QLQ-C30) was rated 'excellent' or good in 82%. 
Conclusions: NRT-CHX is associated with an acceptable 
radiotherapeutic toxicity and a good cosmetic outcome. 
   
PO-0688   
Implementation of a breath-hold lung gating system for 
left-sided breast cancer; hurdles and benefits 
R. Sweeney1, J. Wilbert1, M. Menge1, A. Gibson1, R. Klement1 
1Strahlentherapie Schweinfurt, Radiation Oncology, 
Schweinfurt, Germany  
 
Purpose/Objective: Left sided breast cancer poses a 
significant challenge in sparing the heart and specifically the 
left descending coronary vessels (LCV). Often, a compromise 
between PTV coverage and OAR sparing must be made. Lung 
Gating is seen as a useful method to maximize both. 
However, it is always associated with increased complexity, 
cost and time. We prospectively evaluated the cost-benefit 
of a modern system implemented in a busy community 
hospital environment.  
Materials and Methods: A lung gating system based on the 
breath-hold technique (SDX, QFix, Avondale PN, USA)  
